Confidence Beyond Compliance

With 1 year to go before the UK’s withdrawal from the EU and the start of the implementation (transitional) phase, the clock is ticking for the pharma and biopharma industries to review their contingency plans. At PharmaLex our expertise covers all aspects of regulatory affairs, pharmacovigilance, supply chain and compliance. With offices in the EU27 and the UK, we are keeping abreast of developments in relation to both future EU and UK regulatory intelligence.

Contact us to discuss how PharmaLex can help you in these challenging times.

What our clients say

We needed a to develop our strategy and PharmaLex had exactly the experience we needed.

Med Device company, UK
Senior QA Director

There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

Large Pharma, Global
VP Regulatory Strategy